# Lineage Cell Therapeutics, Inc.: filings

LCTX · NYSE · CIK 876343 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lctx.md) · [Financials](/companies/lctx/financials.md) · [Filings](/companies/lctx/filings.md) · [Insiders](/companies/lctx/insiders.md)

## Reports and events: 621 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 452, 4 376, 10-Q 53, 5 53, SC 13D/A 53, 3 37, CORRESP 26, DEFA14A 25, UPLOAD 22, 424B5 21, DEF 14A 20, EFFECT 20, 10-K 18, S-3 16, CT ORDER 15, 10-K/A 13, S-8 9, POS AM 8, S-3/A 8, 424B3 7, 425 7, D 7, PRE 14A 6, 4/A 5, 5/A 5, SC 13D 5, 8-K/A 4, ARS 4, SC 13G 4, 3/A 3, SCHEDULE 13G 3, 144 2, 25-NSE 2, 8-A12B 2, D/A 2, DFAN14A 2, PRER14A 2, RW 2, SCHEDULE 13D/A 2, SCHEDULE 13G/A 2, 10-Q/A 1, CERTNYS 1, DEFR14A 1, DEL AM 1, S-4 1, S-4/A 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:16 ET | [10-Q](/filings/0001193125-26-338064.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338064 |
| 2026-08-06 | 16:11 ET | [8-K](/filings/0001193125-26-338020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338020 |
| 2026-06-12 | 16:32 ET | [8-K](/filings/0001193125-26-269557.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-269557 |
| 2026-05-12 | 16:15 ET | [10-Q](/filings/0001193125-26-219479.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219479 |
| 2026-05-12 | 16:10 ET | [8-K](/filings/0001193125-26-219421.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219421 |
| 2026-04-29 | 16:10 ET | [DEF 14A](/filings/0001193125-26-191556.md) | Proxy statement, period 2026-04-29 | 0001193125-26-191556 |
| 2026-03-11 | 09:00 ET | [8-K](/filings/0001193125-26-101167.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-101167 |
| 2026-03-05 | 16:16 ET | [10-K](/filings/0001193125-26-093992.md) | Annual report, period 2025-12-31 | 0001193125-26-093992 |
| 2026-03-05 | 16:10 ET | [8-K](/filings/0001193125-26-093948.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-093948 |
| 2025-11-28 | 16:05 ET | [8-K](/filings/0001193125-25-302552.md) | 8.01 Other events | 0001193125-25-302552 |
| 2025-11-24 | 06:49 ET | [8-K](/filings/0001193125-25-291979.md) | 8.01 Other events | 0001193125-25-291979 |
| 2025-11-14 | 18:12 ET | [SCHEDULE 13D/A](/filings/0000919574-25-007051.md) | Ownership report, active investor, amended | 0000919574-25-007051 |
| 2025-11-12 | 09:25 ET | [8-K](/filings/0001193125-25-276249.md) | 8.01 Other events | 0001193125-25-276249 |
| 2025-11-06 | 16:18 ET | [10-Q](/filings/0001193125-25-269599.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269599 |
| 2025-11-06 | 16:12 ET | [8-K](/filings/0001193125-25-269534.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269534 |
| 2025-08-26 | 09:14 ET | [8-K](/filings/0000950170-25-111319.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-111319 |
| 2025-08-12 | 16:16 ET | [10-Q](/filings/0000950170-25-107333.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107333 |
| 2025-08-12 | 16:10 ET | [8-K](/filings/0000950170-25-107314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107314 |
| 2025-07-02 | 16:25 ET | [8-K](/filings/0000950170-25-093007.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-093007 |
| 2025-06-23 | 09:26 ET | [8-K](/filings/0000950170-25-088738.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088738 |
| 2025-06-09 | 17:25 ET | [8-K](/filings/0000950170-25-083866.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-083866 |
| 2025-05-13 | 16:15 ET | [10-Q](/filings/0000950170-25-070378.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070378 |
| 2025-05-13 | 16:10 ET | [8-K](/filings/0000950170-25-070337.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070337 |
| 2025-05-01 | 09:09 ET | [8-K](/filings/0000950170-25-061466.md) | 8.01 Other events | 0000950170-25-061466 |
| 2025-04-29 | 16:05 ET | [DEF 14A](/filings/0000950170-25-060090.md) | Proxy statement, period 2025-06-26 | 0000950170-25-060090 |
| 2025-03-10 | 16:15 ET | [10-K](/filings/0000950170-25-036309.md) | Annual report, period 2024-12-31 | 0000950170-25-036309 |
| 2025-03-10 | 16:10 ET | [8-K](/filings/0000950170-25-036278.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036278 |
| 2025-01-28 | 20:07 ET | [SCHEDULE 13D/A](/filings/0000919574-25-000556.md) | Ownership report, active investor, amended | 0000919574-25-000556 |
| 2025-01-27 | 16:30 ET | [8-K](/filings/0000950170-25-009227.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-009227 |
| 2024-12-09 | 16:30 ET | [DEF 14A](/filings/0000950170-24-134577.md) | Proxy statement, period 2024-12-09 | 0000950170-24-134577 |
| 2024-11-21 | 20:05 ET | [SC 13D/A](/filings/0000919574-24-006855.md) | Ownership report, active investor, amended | 0000919574-24-006855 |
| 2024-11-20 | 17:08 ET | [8-K](/filings/0000950170-24-129402.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-129402 |
| 2024-11-14 | 16:15 ET | [10-Q](/filings/0000950170-24-127077.md) | Quarterly report, period 2024-09-30 | 0000950170-24-127077 |
| 2024-11-14 | 16:10 ET | [8-K](/filings/0000950170-24-127058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-127058 |
| 2024-08-08 | 16:15 ET | [10-Q](/filings/0000950170-24-094004.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094004 |
| 2024-08-08 | 16:10 ET | [8-K](/filings/0000950170-24-093947.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093947 |
| 2024-06-14 | 17:00 ET | [8-K](/filings/0000950170-24-073769.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-24-073769 |
| 2024-06-13 | 16:30 ET | [8-K](/filings/0000950170-24-073072.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-073072 |
| 2024-05-14 | 16:39 ET | [8-K](/filings/0000950170-24-059689.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-059689 |
| 2024-05-09 | 16:15 ET | [10-Q](/filings/0000950170-24-056998.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056998 |
| 2024-05-09 | 16:10 ET | [8-K](/filings/0000950170-24-056948.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056948 |
| 2024-04-29 | 16:30 ET | [DEF 14A](/filings/0000950170-24-049935.md) | Proxy statement, period 2024-06-11 | 0000950170-24-049935 |
| 2024-03-22 | 16:15 ET | [8-K](/filings/0000950170-24-035365.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-035365 |
| 2024-03-07 | 16:21 ET | [10-K](/filings/0000950170-24-027988.md) | Annual report, period 2023-12-31 | 0000950170-24-027988 |
| 2024-03-07 | 16:10 ET | [8-K](/filings/0000950170-24-027951.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-027951 |
| 2024-02-15 | 17:27 ET | [8-K](/filings/0001493152-24-006901.md) | 8.01 Other events | 0001493152-24-006901 |
| 2024-02-08 | 18:57 ET | [SC 13D/A](/filings/0000919574-24-000756.md) | Ownership report, active investor, amended | 0000919574-24-000756 |
| 2024-02-06 | 09:20 ET | [8-K](/filings/0001493152-24-005046.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-005046 |
| 2023-11-09 | 16:15 ET | [10-Q](/filings/0001493152-23-040058.md) | Quarterly report, period 2023-09-30 | 0001493152-23-040058 |
| 2023-11-09 | 16:10 ET | [8-K](/filings/0001493152-23-040057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040057 |

Page 1 of 13. [Older](/companies/lctx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.